株価
24.71
毎日の変更
0.02 0.08%
毎月
10.07%
毎年
-37.12%
Q2 予測
23.58




自己資本および準備金 変化する 日付
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Immunic USD -6.67M 17.17M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Kyowa Hakko Kirin JPY 893.33B 47.21B 2025-12
MacroGenics USD 55.59M 11.41M 2025-12
Moderna USD 7.41B 1.24B 2026-03
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12
Xoma USD 87.94M 15.5M 2025-09